Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyProvidence Health Plan Total PSA Coverage | OpenPa…
    Ask Trek AI about this page
    CurrentProvidence Health PlanPolicy 320

    Prostate Specific Antigen

    Customize your policy alerts

    Sign up for Providence Health Plan Policy 320 alerts

    Get alerted when Policy 320 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This Medicare-only policy governs coverage and billing of total prostate-specific antigen (PSA) testing. Coverage follows CMS NCD 190.31 and applicable medical-necessity and diagnosis-code requirements; screening PSA testing is outside this policy.

    Policy Summary
    PayerProvidence Health Plan
    PolicyProstate Specific Antigen
    Policy CodePolicy 320
    Change TypeAnnual reviewno material changes
    Effective DateNov 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionBill total PSA with an ICD-10-CM diagnosis code from the current CMS NCD 190.31 coding materials.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Medicare onlyProduct and benefit application
    CPT 84153Covered total PSA laboratory code
    NCD 190.31Governing Medicare coverage reference
    No prior authorizationAuthorization status

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Screening excluded
    PSA screening limitation
    No changesRevision history

    Medicare Coverage Criteria

    Medicare-covered total PSA testing

    CPT 84153 may be covered under Medicare guidelines when all applicable CMS NCD 190.31 requirements are met.

    Medicare coverage requirements

    • Billing and diagnosis requirements: Bill total prostate-specific antigen (PSA) testing using CPT 84153 with an ICD-10-CM diagnosis code included in the most current Medicare NCD Coding Policy Manual and Change Report for NCD 190.31.Use the version applicable to the date the service was or will be rendered.

      The diagnosis code must be included in Medicare's current medically necessary code list.

    • Medical necessity requirements: All applicable medical-necessity criteria in NCD 190.31 must be met.

      Utilization may be subject to audit, and inclusion of an eligible diagnosis code does not guarantee automatic coverage.

    Screening PSA tests are outside the scope of this policy and are not addressed by CMS NCD 190.31. Do not report screening PSA testing using CPT 84153.

    Services or items that are cosmetic, not medical in nature, or not medically reasonable and necessary under Title XVIII of the Social Security Act, §1862(a)(1)(A), may be excluded from coverage.

    Billing and Coding

    Covered CPT CodesCPTCovered
    84153Prostate specific antigen (PSA); total
    HCPCSHCPCS
    No codes listed

    Provider and Billing Requirements

    Documentation Required

    Document an Eligible Medicare Diagnosis Code

    Before submitting CPT 84153, document and report an ICD-10-CM diagnosis code that Medicare identifies as medically necessary for NCD 190.31. Use the most current CMS NCD Coding Policy Manual and Change Report coding materials applicable to the date of service.

    • Select the Lab Code List ICD10 (ZIP) file applicable to the service date and locate NCD 190.31 in column A.
    • Verify that the reported diagnosis code appears on the applicable CMS covered-code list; inclusion on the list does not by itself guarantee coverage.
    Documentation Required

    Support NCD Medical Necessity

    Claims for CPT 84153 must support all applicable medical-necessity requirements in CMS NCD 190.31. Although prior authorization is not required, services may be audited and denied when documentation or claims do not establish the NCD criteria.

    • Ensure the medical record supports the diagnosis, indication, and other applicable NCD 190.31 requirements.
    • Review the current NCD and related CMS billing guidance for coverage and utilization limitations.

    Policy Background

    This Medicare-only policy addresses laboratory testing for total prostate-specific antigen (PSA). Coverage is determined under CMS National Coverage Determination (NCD) 190.31 and applicable Medicare medical-necessity and diagnosis-coding requirements. If this policy conflicts with current CMS guidance, CMS guidance governs.

    Defined Service

    Total PSA
    TestProstate specific antigen (PSA); total
    CPT code84153
    Prior authorizationNot required; utilization may be subject to audit

    Covered Total PSA Indication

    Total PSA testing meeting CMS NCD 190.31 requirements

    Total PSA testing is covered when all applicable Medicare medical-necessity, coding, and benefit requirements are satisfied.

    Covered indication requirements

    • Billing and diagnosis requirements: Bill total prostate-specific antigen (PSA) testing using CPT 84153 with an ICD-10-CM diagnosis code included in the current Medicare NCD Coding Policy Manual and Change Report for NCD 190.31.Use the version applicable to the date the service was or will be rendered.

      The diagnosis code must support medical necessity under the NCD.

    • Audit and benefit limitations: Documentation and the claim must support all applicable NCD 190.31 criteria.

      Utilization may be audited, and listing an eligible diagnosis code does not guarantee payment or automatic coverage.

    Services Outside Coverage

    Screening PSA testing is outside the scope of this policy and CMS NCD 190.31. Screening PSA testing should not be reported with CPT 84153.

    Policy Summary
    PayerProvidence Health Plan
    PolicyProstate Specific Antigen
    Policy CodePolicy 320
    Change TypeAnnual reviewno material changes
    Effective DateNov 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionBill total PSA with an ICD-10-CM diagnosis code from the current CMS NCD 190.31 coding materials.
    SourceLink
    On This Page
    Medicare Coverage CriteriaBilling and CodingProvider and Billing RequirementsPolicy BackgroundDefined ServiceCovered Total PSA IndicationServices Outside Coverage
    Denial Risk

    Screening or Excluded Services

    Do not report screening PSA testing or services excluded by Medicare or the member’s benefit plan under CPT 84153. Screening PSA tests are not addressed by this policy or NCD 190.31 and should not be billed with CPT 84153.

    • Review the member’s Evidence of Coverage and applicable Medicare exclusions when coverage is uncertain.
    • Excluded services may include services that are not medical in nature or are not reasonable and necessary under Title XVIII, §1862(a)(1)(A).
    Denial Risk

    NCD Criteria and Diagnosis Requirements

    Claims may be denied when the reported diagnosis is not an eligible Medicare code or when the medical record and claim do not demonstrate that applicable NCD 190.31 criteria were met. A diagnosis code’s presence on the CMS list does not warrant automatic coverage.

    • Use the current CMS NCD 190.31 covered-code list for the date of service.
    • Confirm that documentation supports the reported diagnosis and the applicable coverage criteria before billing.

    Unsupported block type: denial_risk

    Unsupported block type: billing_rule